Skip to main content

A Phase 3, Randomized, Open-Label, Parallel-Group Study to Compare the Pharmacodynamics, Pharmacokinetics, Efficacy, Safety, Tolerability, and Immunogenicity of Multiple Subcutaneous Injections of Efg

Clinical Trial Grant
Duke Scholars

Administered By

School of Medicine

Awarded By

Argenx BVBA

Start Date

May 19, 2021

End Date

September 13, 2022
 

Administered By

School of Medicine

Awarded By

Argenx BVBA

Start Date

May 19, 2021

End Date

September 13, 2022